Welcome to our dedicated page for Zimmer Biomet Holdings news (Ticker: $ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zimmer Biomet Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zimmer Biomet Holdings's position in the market.
Zimmer Biomet, a global leader in medical technology, will host its 2024 Investor Day on May 29, 2024, from 1:00 p.m. to 4:30 p.m. ET at the New York Stock Exchange. Key presentations will be given by President and CEO Ivan Tornos and CFO Suky Upadhyay, covering the company's strategic and capital allocation priorities, key initiatives, and long-term financial goals. The event will also feature a surgeon panel discussion and Q&A sessions, followed by a reception and product showcase. In-person attendance requires pre-registration via the company's Investor Relations website. The event will be webcast live, with a replay and presentations available afterward.
Zimmer Biomet Holdings, a medical technology leader, announced a quarterly cash dividend of $0.24 per share for the second quarter of 2024, payable on July 31, 2024.
Zimmer Biomet Holdings, Inc. published its 2023 Sustainability Report highlighting progress in environmental goals, employee engagement, health equity, and quality management. The report showcases the company's commitment to sustainability, including achieving high employee engagement levels, reducing carbon emissions, expanding Zero Waste to Landfill initiative, and maintaining product quality programs. Zimmer Biomet aims to be a leader in responsible business practices and has a roadmap to reach Net-Zero greenhouse gas emissions by 2050.
Zimmer Biomet Holdings, Inc. reported first quarter net sales of $1.889 billion, with a 3.2% increase over the prior year. Diluted earnings per share were $0.84, adjusted diluted earnings per share were $1.94. Recent highlights include FDA clearances for innovative products and partnerships with pickleball organizations. The company reaffirmed its full-year 2024 financial guidance.